Edition:
United Kingdom

Strides Shasun Ltd (STSA.NS)

STSA.NS on National Stock Exchange of India

799.50INR
10:23am GMT
Change (% chg)

Rs-3.15 (-0.39%)
Prev Close
Rs802.65
Open
Rs805.05
Day's High
Rs809.00
Day's Low
Rs795.80
Volume
251,992
Avg. Vol
534,315
52-wk High
Rs1,274.70
52-wk Low
Rs752.30

Latest Key Developments (Source: Significant Developments)

Eris Lifesciences Says ‍Divestment Of Strides Shasun's India Brand Business To Co Completed
Monday, 4 Dec 2017 

Dec 4 (Reuters) - Eris Lifesciences Ltd ::SAYS ‍DIVESTMENT OF STRIDES SHASUN'S INDIA BRAND BUSINESS TO CO COMPLETED.  Full Article

Strides Shasun gets U.S. FDA approval for acetazolamide tablets​
Wednesday, 22 Nov 2017 

Nov 22 (Reuters) - Strides Shasun Ltd :Says ‍receives USFDA approval for acetazolamide tablets​.Says product to be marketed by Strides Pharma Inc in the US market‍​.  Full Article

India's Strides Shasun Sept-qtr consol profit down 87 pct
Tuesday, 31 Oct 2017 

Oct 31 (Reuters) - Strides Shasun Ltd ::Sept quarter consol net profit 107.3 million rupees versus profit of 854.3 million rupees last year.Sept quarter consol revenue from operations 9.96 billion rupees versus 8.72 billion rupees last year.  Full Article

Strides Shasun gets USFDA approval for cetirizine softgel capsules
Monday, 24 Jul 2017 

July 24 (Reuters) - Strides Shasun Ltd ::Says receives USFDA approval for cetirizine softgel capsules.Says product is ready for launch immediately.Says product will be manufactured at co's Bangalore facility and marketed by Strides Pharma Inc in U.S.‍​.  Full Article

Strides Shasun says API site at Puducherry gets 'zero 483 status' by U.S. FDA
Friday, 5 May 2017 

May 5 (Reuters) - Strides Shasun Ltd :Strides shasun announces successful completion of third consecutive US FDA inspection with 'zero 483 status' over last month.API site at Puducherry's US FDA approval renewed with zero 483 status.  Full Article

Strides Shasun gets FDA nod for drug to treat HIV-1
Tuesday, 1 Nov 2016 

Strides Shasun Ltd : Says Strides Shasun receives usfda approval for abacavir tablets . Says product will be manufactured at the company’s USFDA approved facility at Bangalore and marketed by Strides in the U.S. market .Says product will be launched immediately.  Full Article

Strides Shasun gets FDA approval for polyethylene glycol 3350, powder for solution (OTC)
Thursday, 25 Aug 2016 

Strides Shasun Ltd : Strides Shasun receives USFDA approval for polyethylene glycol 3350, powder for solution (OTC) .  Full Article

Strides Shasun gets USFDA approval for ranitidine tablets
Wednesday, 24 Aug 2016 

Strides Shasun Ltd : Strides Shasun receives USFDA approval for ranitidine tablets .  Full Article

Strides Shasun June-qtr profit more than doubles
Wednesday, 17 Aug 2016 

Strides Shasun Ltd : June-quarter net profit 260.4 million rupees . June-quarter net sales 8.45 billion rupees . Net profit in June-quarter last year was 106.2 million rupees as per Ind-AS; net sales was 5.84 billion rupees .  Full Article

Strides Shasun to hive off API business to unit
Wednesday, 17 Aug 2016 

Strides Shasun Ltd : To hive off API business to unit .  Full Article

BRIEF-Eris Lifesciences Says ‍Divestment Of Strides Shasun's India Brand Business To Co Completed

* SAYS ‍DIVESTMENT OF STRIDES SHASUN'S INDIA BRAND BUSINESS TO CO COMPLETED Source text - http://bit.ly/2kkCPEo Further company coverage: